Search

Author/Creator Hazard, Sebastien J.

1. Effectiveness of bevacizumab exposure beyond disease progression in patients with non–small‐cell lung cancer: analyses of the ARIES observational cohort study†. Issue 5 (8th January 2016)

Authors:
Leon, Larry; Kosty, Michael; Jahanzeb, Mohammad; Spigel, David; Wozniak, Antoinette J.; Brahmer, Julie; Fish, Susan; Flick, E. Dawn; Hazard, Sebastien J.; Lynch, Thomas J.
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 25:Issue 5(2016)
Page Start:
569
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non–Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials. (October 2016)

Authors:
Langer, Corey J.; Socinski, Mark A.; Patel, Jyoti D.; Sandler, Alan B.; Schiller, Joan H.; Leon, Larry; Hazard, Sebastien J.; Ramalingam, Suresh S.
Journal:
American journal of clinical oncology
Issue:
Volume 39:Number 5(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗